Sejal Saglani

Sejal Saglani

Auto-generated profile, based on publicly available information

Sejal Saglani

Royal Brompton Hospital London UK

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2014 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
EGEva S Gollwitzer
Eva S Gollwitzer
SSSejal Saglani
Sejal Saglani
ATAurélien Trompette
Aurélien Trompette
KYKoshika Yadava
Koshika Yadava
RSRebekah Sherburn
Rebekah Sherburn
BMBenjamin J Marsland
Benjamin J Marsland

1 November 2007 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
SSSejal Saglani
Sejal Saglani
DPDonald N. Payne
Donald N. Payne
JZJie Zhu
Jie Zhu
ZWZhuo Wang
Zhuo Wang
ANAndrew G. Nicholson
Andrew G. Nicholson
PJPeter K. Jeffery
Peter K. Jeffery
Rationale: It is unclear when the pathologic features of asthma first appear. We hypothesized that eosinophilic airway inflammation and epithelial reticular basement membrane (RBM) thickening, absent in wheezy infants, would be present in preschool children with severe, recurrent wheeze. Objectives: To compare RBM thickness and inflammation in endobronchial biopsies (EBs) from wheezy preschool children and age-matched control subjects. Methods: EBs were obtained from wheezy preschool children (aged 3 mo to 5 yr), undergoing a clinically indicated fiberoptic bronchoscopy. Subjects undergoing fiberoptic bronchoscopy to investigate stridor acted as nonasthmatic controls. RBM thickness was measured and the density of subepithelial, immunologically distinct inflammatory cells was determined and expressed as a volume fraction (%). EBs from 16 children (median age, 29 [7–57] mo) with wheeze confirmed by video questionnaire (confirmed wheezers [CWs]), 14 with reported wheeze (reported wheezers [RWs]) (median age, 17 [8–58] mo), and 10 control subjects (median age, 19 [5–42] mo) were assessed. Measurements and Main Results: RBM thickness in the three groups was as follows: CWs: median, 4.6 (range, 2.9–8.0) μm; RWs: median, 3.5 (2.1–5.4) μm; control subjects: median, 3.8 (2.5–4.7) μm. RBM was significantly thicker in CWs than in control subjects (P < 0.05). Eosinophil density was as follows: CWs: median, 1.07% (range, 0.0–3.52%); RWs: median, 0.72% (0.0–2.04%); control subjects: median, 0.0% (0.0–1.05%). Eosinophilic inflammation was significantly greater in CWs compared with control subjects (P < 0.05). There were no between-group differences for any other inflammatory cell phenotype. Conclusions: The characteristic pathologic features of asthma in adults and school-aged children develop in preschool children with confirmed wheeze between the ages of 1 and 3 years, a time when intervention may modify the natural history of asthma.

1 April 2005 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
SSSejal Saglani
Sejal Saglani
KMKristiina Malmström
Kristiina Malmström
APAnna S. Pelkonen
Anna S. Pelkonen
LML. Pekka Malmberg
L. Pekka Malmberg
HLHarry Lindahl
Harry Lindahl
PJPeter K. Jeffery
Peter K. Jeffery
Rationale: We hypothesized that the epithelial reticular basement membrane (RBM) thickening and eosinophilic inflammation characteristic of asthma would be present in symptomatic infants with reversible airflow obstruction. Methods: RBM thickness and numbers of inflammatory cells were determined in ultrathin sections of endobronchial biopsies obtained from 53 infants during clinical bronchoscopy for severe wheeze and/or cough. Group A: 16 infants with a median age of 12 months (range 3.4–26 months), with decreased specific airway conductance (sGaw) and bronchodilator reversibility; Group B: 22 infants with a median age of 12.4 months (5.1–25.9 months), with decreased sGaw but without bronchodilator reversibility; and Group C: 15 infants with a median age of 11.5 months (3.4–24.3 months) with normal sGaw. Additional comparisons were made with the following groups. Group D: 17 children, median age 10.3 years (6–16 years), with difficult asthma; Group E: 10 pediatric control subjects without asthma, median age 10 years (6–16 years); and Group F: nine adult normal, healthy control subjects, median age 27 years (21–42 years). Main Results: There were no significant differences in RBM thickness or inflammatory cell number between the infant groups. RBM thickness was similar in the infants and Groups E and F. However, the RBM in all infant groups (Group A: median 4.3 μm [range 2.8–9.2 μm]; Group B: median 4.15 μm [range 2.7–5.8 μm]; Group C: median 3.8 μm [range 2.7–5.5 μm]) was significantly less thick than that in the older children with asthma (Group D: median 8.3 μm [range 5.3–12.7 μm]; p < 0.001). Conclusion: RBM thickening and the eosinophilic inflammation characteristic of asthma in older children and adults are not present in symptomatic infants with reversible airflow obstruction, even in the presence of atopy.

1 April 2012 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
CBCara J. Bossley
Cara J. Bossley
LFLouise Fleming
Louise Fleming
AGAtul Gupta
Atul Gupta
NRNicolas Regamey
Nicolas Regamey
JFJennifer Frith
Jennifer Frith
SSSejal Saglani
Sejal Saglani

15 December 2011 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
AGAtul Gupta
Atul Gupta
ASAlies Sjoukes
Alies Sjoukes
DRDavid Richards
David Richards
WBWinston Banya
Winston Banya
CHCatherine Hawrylowicz
Catherine Hawrylowicz
SSSejal Saglani
Sejal Saglani
Rationale: Little is known about vitamin D status and its effect on asthma pathophysiology in children with severe, therapy-resistant asthma (STRA). Objectives: Relationships between serum vitamin D, lung function, and pathology were investigated in pediatric STRA. Methods: Serum 25-hydroxyvitamin D [25(OH)D3] was measured in 86 children (mean age, 11.7 yr): 36 with STRA, 26 with moderate asthma (MA), and 24 without asthma (control subjects). Relationships between 25(OH)D3, the asthma control test (ACT), spirometry, corticosteroid use, and exacerbations were assessed. Twenty-two of 36 children with STRA underwent fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy with assessment of airway inflammation and remodeling. Measurements and Main Results: 25(OH)D3 levels (median [IQR]) were significantly lower in STRA (28 [22–38] nmol/L) than in MA (42.5 [29–63] nmol/L) and control subjects (56.5 [45–67] nmol/L) (P < 0.001). There was a positive relationship between 25(OH)D3 levels and percent predicted FEV1 (r = 0.4, P < 0.001) and FVC (r = 0.3, P = 0.002) in all subjects. 25(OH)D3 levels were positively associated with ACT (r = 0.6, P < 0.001), and inversely associated with exacerbations (r = –0.6, P < 0.001) and inhaled steroid dose (r = –0.39, P = 0.001) in MA and STRA. Airway smooth muscle (ASM) mass, but not epithelial shedding or reticular basement membrane thickness, was inversely related to 25(OH)D3 levels (r = –0.6, P = 0.008). There was a positive correlation between ASM mass and bronchodilator reversibility (r = 0.6, P = 0.009) and an inverse correlation between ASM mass and ACT (r = –0.7, P < 0.001). Conclusions: Lower vitamin D levels in children with STRA were associated with increased ASM mass and worse asthma control and lung function. The link between vitamin D, airway structure, and function suggests vitamin D supplementation may be useful in pediatric STRA.

1 September 2013 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
SSSejal Saglani
Sejal Saglani
SLStephen Lui
Stephen Lui
NUNicola Ullmann
Nicola Ullmann
GCGaynor A. Campbell
Gaynor A. Campbell
RSRebekah Sherburn
Rebekah Sherburn
CLClare M. Lloyd
Clare M. Lloyd